Roche Inks Another AAV Capsid Platform Technology Deal, With Avista Therapeutics

 
• By Alaric DeArment
  
Avista and Roche signed a deal to use Avista's capsid technology in developing gene therapies for eye diseases • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business